Among the twelve peptides removed from the Category 2 list (effective April 23, 2026): Removal from Category 2 is separate from the FDAs review of which peptides may be compounded under section 503A
The purpose behind microdosing strategies generally centers on three main objectives: reducing the incidence and severity of gastrointestinal side effects such as nausea, vomiting, and diarrhea
Suzanne Fenske, M.D., assistant professor of obstetrics, gynecology, and reproductive science at Mount Sinai, anywhere from 60 to 80 percent of women will experience uterine fibroids at some point in their lives
PubMed Wessells H, Levine N, Hadley ME, Dorr R, Hruby VJ (2000)
GLP-1 (glucagon-like peptide-1) is a hormone your body produces naturally